SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-012520
Filing Date
2021-05-17
Accepted
2021-05-17 16:10:08
Documents
15
Period of Report
2021-05-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20210516_8k.htm   iXBRL 8-K 24187
2 EXHIBIT 99.1 ex_250590.htm EX-99.1 84033
7 logo.jpg GRAPHIC 9303
  Complete submission text file 0001437749-21-012520.txt   269471

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrx-20210517.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20210517_def.xml EX-101.DEF 11975
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20210517_lab.xml EX-101.LAB 16020
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20210517_pre.xml EX-101.PRE 12184
8 EXTRACTED XBRL INSTANCE DOCUMENT acrx20210516_8k_htm.xml XML 2665
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 21930614
SIC: 2834 Pharmaceutical Preparations